(Q34776831)

English

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure-a meta-regression analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

0 references

0 references

meta-regression

1 reference

based on heuristic

inferred from title

author name string

Simon Thackray

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Joanne Easthaugh

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Nick Freemantle

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

John G F Cleland

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

515-529

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Recognising the limits of randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Dobutamine: A New Synthetic Cardioactive Sympathetic Amine

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Comparative hemodynamic effects of dopamine and dobutamine in patients with acute cardiogenic circulatory collapse.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Efficacy and safety of sustained (48 hour) intravenous infusions of milrinone in patients with severe congestive heart failure: a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Amrinone in cardiac surgical patients with left-ventricular dysfunction. A prospective, randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Effects of a novel inotropic agent (OPC-18790) on systolic and diastolic function in patients with severe heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Bayesian approaches to random-effects meta-analysis: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Meta-analysis for 2 x 2 tables: a Bayesian approach

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

A likelihood approach to meta-analysis with random effects

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

What do the newer inotropic drugs have to offer?

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Heart failure update.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Deactivation of the sympathetic nervous system in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

21 January 2018

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Multicenter, double-blind study of intravenous milrinone for patients with acute heart failure in Japan. Japan Intravenous Milrinone Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Adrenergic regulation of the force-frequency effect

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Short- and long-term dobutamine treatment in chronic ischemic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance to dobutamine after a 72 hour continuous infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of a short-term (6-h) intravenous infusion of dopexamine in patients with severe congestive heart failure: A randomized, double-blind, parallel, placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous dopexamine in the treatment of acute congestive heart failure: results of a multicenter, double-blind, placebo-controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of dobutamine and OPC-18790 on diastolic chamber stiffness in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trials update: Highlights of the Scientific Sessions of Heart Failure 2001, a meeting of the Working Group on Heart Failure of the European Society of Cardiology. CONTAK-CD, CHRISTMAS, OPTIME-CHF

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The LIDO, HOPE, MOXCON and WASH studies

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2802%2900041-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1388-9842(02)00041-7

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34776831&oldid=1625628423"